AI for accelerated antibody discovery Traditionally ... In addition to its proprietary generative AI, the company has its own automation platform to rapidly synthesise and test antibodies in ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

2 Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of bispecific antibodies while reducing costs and enhancing downstream ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...